(XD9D) Xtrackers MSCI USA 1D - Ratings and Ratios
US Stocks, Large Cap, Equities
Description: XD9D Xtrackers MSCI USA 1D
The Xtrackers MSCI USA UCITS ETF1D (XD9D) is a US Large-Cap Blend Equity ETF listed on XETRA, originating from Germany. It tracks the Morningstar US Large-Mid NR USD Index, providing investors with exposure to a broad range of large and mid-cap US stocks.
From a performance perspective, the ETF has demonstrated relatively stable price action, with its 20-day, 50-day, and 200-day Simple Moving Averages (SMA) indicating a lack of strong trend direction. The Average True Range (ATR) of 0.11 (0.55%) suggests moderate daily price volatility. To further assess its performance, key metrics such as the ETFs tracking error, information ratio, and beta relative to its benchmark index could be examined.
In terms of assets under management (AUM), XD9D has a relatively modest size of €264.82 million. To put this into perspective, a larger AUM typically indicates higher liquidity and potentially lower expense ratios due to economies of scale. Other key performance indicators (KPIs) to consider when evaluating XD9D include its expense ratio, dividend yield, and turnover rate, which can provide insights into its cost efficiency, income generation, and potential tax implications.
To make a more informed investment decision, it is essential to analyze XD9Ds holdings, sector allocation, and market capitalization distribution. This information can help investors understand the ETFs exposure to various market segments and potential risks associated with its investment strategy. Additionally, comparing XD9Ds performance and characteristics to those of its peers and benchmark index can provide valuable context for evaluating its overall investment merit.
Additional Sources for XD9D ETF
XD9D ETF Overview
Market Cap in USD | 308m |
Category | US Large-Cap Blend Equity |
TER | 0.07% |
IPO / Inception | 2021-02-18 |
XD9D ETF Ratings
Growth Rating | 60.2 |
Fundamental | - |
Dividend Rating | 59.0 |
Rel. Strength | -6.19 |
Analysts | - |
Fair Price Momentum | 19.95 EUR |
Fair Price DCF | - |
XD9D Dividends
Dividend Yield 12m | 1.03% |
Yield on Cost 5y | 1.79% |
Annual Growth 5y | 54.44% |
Payout Consistency | 100.0% |
Payout Ratio | % |
XD9D Growth Ratios
Growth Correlation 3m | 78.3% |
Growth Correlation 12m | 16% |
Growth Correlation 5y | 86% |
CAGR 5y | 13.49% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 0.36 |
Alpha | -6.25 |
Beta | 0.811 |
Volatility | 16.57% |
Current Volume | 6.8k |
Average Volume 20d | 5.3k |
Stop Loss | 20.3 (-3.2%) |
As of July 20, 2025, the stock is trading at EUR 20.97 with a total of 6,771 shares traded.
Over the past week, the price has changed by +1.07%, over one month by +3.81%, over three months by +18.47% and over the past year by +7.86%.
Yes. Based on ValueRay's Analyses, Xtrackers MSCI USA 1D (XETRA:XD9D) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 60.21 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XD9D is around 19.95 EUR . This means that XD9D is currently overvalued and has a potential downside of -4.86%.
Xtrackers MSCI USA 1D has no consensus analysts rating.
According to our own proprietary Forecast Model, XD9D Xtrackers MSCI USA 1D will be worth about 23.1 in July 2026. The stock is currently trading at 20.97. This means that the stock has a potential upside of +10.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 23.1 | 10.1% |